---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-055658"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2023-07-10T23:59:59+00:00"
generated_at: "2026-06-13T10:34:46.037870+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics closes full exercise of IPO over-allotment, raises $22.425M gross

## Summary
- Total gross proceeds from upsized IPO and full over-allotment exercise: $22.425 million.
- Underwriters exercised option to purchase 585,000 additional shares at $5.00, adding $2.925M gross.
- Net proceeds to Intensity after underwriting discounts and expenses: approximately $18.9 million.
- Joint book-running managers: The Benchmark Company and Freedom Capital Markets.
- Closing and full exercise announced July 10, 2023.

## SEC filing metadata
- accession: 0001213900-23-055658
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2023-07-10T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000121390023055658/0001213900-23-055658-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000121390023055658/ea181449-8k_intensity.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-055658
- JSON: https://secwatch.observer/filing/0001213900-23-055658.json
- Plain text: https://secwatch.observer/filing/0001213900-23-055658.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.